✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects

✍ Scribed by Brian D. Guth; Hans Narjes; Hans-Dieter Schubert; Paul Tanswell; Axel Riedel; Gerhard Nehmiz

Book ID: 108640116
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 290 KB
Volume: 58
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2004.02083.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Guanidine Derivatives as Combined Thromb

Guanidine Derivatives as Combined Thromboxane A 2 Receptor Antagonists and Synthase Inhibitors

✍ Soyka, Rainer; Guth, Brian D.; Weisenberger, Hans M.; Luger, Peter; Müller, Thom 📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 524 KB

Pharmacokinetics, Pharmacodynamics and T

Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects

✍ Luis Almeida, José Francisco Rocha, Amílcar Falcão, P. Nuno Palma, Ana I. Lourei 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 699 KB

Pharmacodynamics and tolerability of DT-

Pharmacodynamics and tolerability of DT-TX 30 SE, a novel combined TXA2/PGH2 receptor blocker and thromboxane synthetase inhibitor, in healthy volunteers

✍ H. Narjes; T.H. Müller; H. Weisenberger; M. Kirchner; G. Deichsel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects

✍ Ulf G. Eriksson; Ulf Bredberg; Kristina Gislén; Linda C. Johansson; Lars Frison; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 291 KB

Design, synthesis and biological evaluat

Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor

✍ Jean-Michel Dogné; Johan Wouters; Stéphanie Rolin; Catherine Michaux; Lionel Poc 📂 Article 📅 2001 🏛 Pharmaceutical Press 🌐 English ⚖ 293 KB

“In vitro” and “ex vivo” effects of pico

“In vitro” and “ex vivo” effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets

✍ M. Berrettini; M. Cunto; P. Parise; S. Grasselli; G. G. Nenci 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 599 KB

Picotamide (G 137), a new non prostanoid inhibitor of in vitro arachidonic acid induced platelet aggregation, has been further characterized in in vitro and ex vivo studies. When whole blood was activated with collagen in the presence of picotamide 5 x 10(-4) M, thromboxane B2 production was decreas